The Regulation of Nucleic Acid Vaccine Responses by the Microbiome
The Journal of Immunology · 2023
DOI: 10.4049/jimmunol.2300196 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, 2023. Verfasst von Andrew M F Johnson und 11 weiteren Autor:innen. Beteiligte Einrichtung: Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA. Hauptthemen laut MEDLINE: Vaccines, DNA, Microbiota. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, Animal Health and Welfare ERA-Net.
Abstract (Originalsprache)
Nucleic acid vaccines, including both RNA and DNA platforms, are key technologies that have considerable promise in combating both infectious disease and cancer. However, little is known about the extrinsic factors that regulate nucleic acid vaccine responses and which may determine their effectiveness. The microbiome is recognized as a significant regulator of immune development and response, whose role in regulating some traditional vaccine platforms has recently been discovered. Using germ-free and specific pathogen-free mouse models in combination with different protein, DNA, and mRNA vaccine regimens, we demonstrate that the microbiome is a significant regulator of nucleic acid vaccine immunogenicity. Although the presence of the microbiome enhances CD8+ T cell responses to mRNA lipid nanoparticle immunization, the microbiome suppresses Ig and CD4+ T cell responses to DNA-prime, DNA-protein-boost immunization, indicating contrasting roles for the microbiome in the regulation of these different nucleic acid vaccine platforms. In the case of mRNA lipid nanoparticle vaccination, germ-free mice display reduced dendritic cell/macrophage activation that may underlie the deficient vaccine response. Our study identifies the microbiome as a relevant determinant of nucleic acid vaccine response with implications for continued therapeutic development and deployment of these vaccines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.
- Penn Institute for RNA Innovation, University of Pennsylvania, Philadelphia, PA.
- Acuitas Therapeutics, Vancouver, BC, Canada.
ORCID-Profile: Kevin Hager, Mohamad-Gabriel Alameh, Phuong Van, Nicole Potchen, Koshlan Mayer-Blackwell, Samuel Minot, Paulo J C Lin, Ying K Tam, Drew Weissman, James G Kublin
Förderung
- NIAID NIH HHS
- Animal Health and Welfare ERA-Net
Zitieren
APA
Johnson, A. M. F., Hager, K., Alameh, M. G., Van, P., Potchen, N., Mayer-Blackwell, K., Fiore-Gartland, A., Minot, S., Lin, P. J. C., Tam, Y. K., Weissman, D., & Kublin, J. G. (2023). The Regulation of Nucleic Acid Vaccine Responses by the Microbiome. The Journal of Immunology. https://doi.org/10.4049/jimmunol.2300196
Vancouver
Johnson AMF, Hager K, Alameh MG, Van P, Potchen N, Mayer-Blackwell K, et al. The Regulation of Nucleic Acid Vaccine Responses by the Microbiome. The Journal of Immunology. 2023. doi:10.4049/jimmunol.2300196
BibTeX
@article{Johnson2023,
author = {Johnson, Andrew M F and Hager, Kevin and Alameh, Mohamad-Gabriel and Van, Phuong and Potchen, Nicole and Mayer-Blackwell, Koshlan and Fiore-Gartland, Andrew and Minot, Samuel and Lin, Paulo J C and Tam, Ying K and Weissman, Drew and Kublin, James G},
title = {The Regulation of Nucleic Acid Vaccine Responses by the Microbiome},
journal = {The Journal of Immunology},
year = {2023},
doi = {10.4049/jimmunol.2300196}
}
EUVIMED